Global Health (Australia) Market Value
GLH Stock | 0.11 0.02 15.38% |
Symbol | Global |
Global Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Global Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Global Health.
12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Global Health on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Global Health or generate 0.0% return on investment in Global Health over 90 days. Global Health is related to or competes with Anteris Technologies, Garda Diversified, British Amer, BKI Investment, and Hudson Investment. Global Health is entity of Australia. It is traded as Stock on AU exchange. More
Global Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Global Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Global Health upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.06) | |||
Maximum Drawdown | 30.77 | |||
Value At Risk | (6.67) |
Global Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Global Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Global Health's standard deviation. In reality, there are many statistical measures that can use Global Health historical prices to predict the future Global Health's volatility.Risk Adjusted Performance | (0.07) | |||
Jensen Alpha | (0.30) | |||
Total Risk Alpha | 0.0934 | |||
Treynor Ratio | (1.59) |
Global Health Backtested Returns
Global Health holds Efficiency (Sharpe) Ratio of -0.0969, which attests that the entity had a -0.0969 % return per unit of risk over the last 3 months. Global Health exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Global Health's Market Risk Adjusted Performance of (1.58), standard deviation of 3.3, and Risk Adjusted Performance of (0.07) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.2, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Global Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Global Health is expected to be smaller as well. At this point, Global Health has a negative expected return of -0.33%. Please make sure to check out Global Health's jensen alpha, value at risk, kurtosis, as well as the relationship between the total risk alpha and skewness , to decide if Global Health performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.08 |
Virtually no predictability
Global Health has virtually no predictability. Overlapping area represents the amount of predictability between Global Health time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Global Health price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Global Health price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.08 | |
Spearman Rank Test | 0.0 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Global Health lagged returns against current returns
Autocorrelation, which is Global Health stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Global Health's stock expected returns. We can calculate the autocorrelation of Global Health returns to help us make a trade decision. For example, suppose you find that Global Health has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Global Health regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Global Health stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Global Health stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Global Health stock over time.
Current vs Lagged Prices |
Timeline |
Global Health Lagged Returns
When evaluating Global Health's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Global Health stock have on its future price. Global Health autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Global Health autocorrelation shows the relationship between Global Health stock current value and its past values and can show if there is a momentum factor associated with investing in Global Health.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Global Stock Analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.